MY138052A - Modafinil pharmaceutical compositions - Google Patents

Modafinil pharmaceutical compositions

Info

Publication number
MY138052A
MY138052A MYPI20032428A MY138052A MY 138052 A MY138052 A MY 138052A MY PI20032428 A MYPI20032428 A MY PI20032428A MY 138052 A MY138052 A MY 138052A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical compositions
modafinil
modafinil pharmaceutical
potency
drug
Prior art date
Application number
Inventor
Piyush Patel
Alpa Parikh
Craig Heacock
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of MY138052A publication Critical patent/MY138052A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PHARMACEUTICAL COMPOSITIONS COMPRISING MODAFINIL IN THE FORM OF PARTICLES OF DEFINED SIZE. THE PARTICLE SIZE OF MODAFINIL CAN HAVE A SIGNIFICANT EFFECT ON THE POTENCY AND SAFETY PROFILE OF THE DRUG.
MYPI20032428 2002-07-12 2003-06-27 Modafinil pharmaceutical compositions MY138052A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39553702P 2002-07-12 2002-07-12

Publications (1)

Publication Number Publication Date
MY138052A true MY138052A (en) 2009-04-30

Family

ID=40490847

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20032428 MY138052A (en) 2002-07-12 2003-06-27 Modafinil pharmaceutical compositions

Country Status (4)

Country Link
AR (1) AR042411A1 (en)
MY (1) MY138052A (en)
UA (1) UA88256C2 (en)
ZA (1) ZA200501100B (en)

Also Published As

Publication number Publication date
UA88256C2 (en) 2009-10-12
AR042411A1 (en) 2005-06-22
ZA200501100B (en) 2006-11-29

Similar Documents

Publication Publication Date Title
CY1107714T1 (en) MODUFINILIUM PHARMACEUTICAL COMPOSITIONS
MX9602176A (en) Modafinil having defined particle size.
MY135852A (en) Pharmaceutical products
ZA200506240B (en) Coated particles and pharmaceutical dosage forms
IL164217A0 (en) Pharmaceutical compositions containing water-soluble propofol and methods of administering same
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
AU2003295092A1 (en) Drug delivery particles and methods of treating particles to improve their drug delivery capabilities
PT1530457E (en) Pharmaceutical compositions of drugs in semi-ordered form and polymers
IL163868A (en) Hemiasterlin derivatives and pharmaceutical compositions comprising them
MXPA05012358A (en) Pharmaceutical combination comprising modafinil and another drug.
EP1543841A4 (en) Soild nano pharmaceutical formulation and preparation method thereof
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
MXPA06000332A (en) Novel solid pharmaceutical composition comprising amisulpride.
SI1849468T1 (en) Pharmaceutical composition comprising roflumilast and levocetirizine
ZA200501714B (en) Analogues of vitamin d
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
MY138052A (en) Modafinil pharmaceutical compositions
AU2001296939A1 (en) Oral delivery method and composition for solid medications or dietary supplements in the form of solid particles
AU2003213402A1 (en) Powdery medicinal compositions for inhalation and process for producing the same
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
AU2003295713A8 (en) Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
NO20043859L (en) Powder composition containing zaleplon with defined particle size distribution and pharmaceutical products thereof
MXPA05005326A (en) Tablet comprising efletirizine and pseudoephedrine.
GB0214751D0 (en) Particle size reduction of poorly soluble drugs
AU2002237181A1 (en) The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy